PTB Pascolizumab

Project no.: HIV-NAT 227

This is a randomized, double-blind, placebo-controlled, proof of concept clinical trial to assess the safety and efficacy of blocking IL4 with Pascolizumab in patients receiving standard combination therapy for pulmonary tuberculosis.